Combination of epristeride and terazosin for treatment of benign prostatic hyperplasia
- VernacularTitle:爱普列特和特拉唑嗪联合应用治疗良性前列腺增生
- Author:
Boyong HU
;
Jin QIU
;
Ming HAN
;
Renjie GONG
;
Honggang ZHU
- Publication Type:Journal Article
- Keywords:
Prostatic hyperplasia;
Drag therapy,combination;
Epristeride;
Terazosin
- From:
Chinese Journal of Postgraduates of Medicine
2008;31(20):16-18
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the security and efficacy of combination of epristeride and terazosin for treatment of benign prostatic hyperplasia (BPH). Method One hundred and eighty-four patients with BPH were treated by epristeride for 6 months and terazosin for 1 month, the efficacy and complication were observed. Results After 6 months treated, compared with before treated, the common symptoms improved, the residual urine decreased 20.74ml, maximum flow rate increased 3.76 ml/s, prostate volume grown downwards 6.70cm3 and the quality of life raised apparently(Pall＜0.05 ). Condusion Combinationof epristeride and terazosin for treatment of BPH is safe and effective.
